Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

TAICANG , JIANGSU, CHINA, December 31, 2025 /EINPresswire.com/ — Climate neutrality and energy efficiency initiatives continue to shape industries across the board, with built environments being one ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

That’s the aim of predictive cyber resilience (PCR)—an emerging approach to security built on intelligence, automation and ...

EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...

Chief Minister Khyber Pakhtunkhwa, Muhammad Sohail Afridi Saturday said that provincial government was working on emerging technologies of biomedicine and advanced materials to promote value addition ...

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...

Chemist Anne Lüscher showed at 39C3 how synthetic DNA can be used for data storage and tamper-proof authentication.

A 25-year-old woman was allegedly gangraped and brutally assaulted by two men in a Maruti Suzuki Eeco van after she accepted ...

Co-Diagnostics ( ($CODX) ) just unveiled an update. On December 5, 2025, Co-Diagnostics’ stockholders approved a reverse stock split ...